Aimovig (erenumab-aooe)

Reviewed by: HU Medical Review Board | Last reviewed: April 2023

Aimovig™ (erenumab-aooe) is a prescription drug used for the preventative treatment of migraine. Aimovig is a type of drug known as a calcitonin-gene-related peptide (CGRP) blocker.1

Aimovig comes in 2 different types of devices:1

  • A single-dose prefilled autoinjector
  • A single-dose prefilled syringe

Your doctor will prescribe the type and dose that is right for you. They will also teach you how to inject Aimovig.1

What are the ingredients in Aimovig?

The active ingredient in Aimovig is erenumab-aooe.1

How does Aimovig work?

CGRP is a protein that acts like a neurotransmitter (a chemical messenger) throughout the brain and body. CGRP is found in large numbers in the sensory nerves that supply the head and neck. Research shows that CGRP is found in high levels during a migraine attack.1

Aimovig works by targeting and binding to CGRP receptors. This stops CGRP from binding to the receptors in sensory nerves, thus stopping migraine attacks that were started by CGRP.1

What are the possible side effects?

The most common side effects of Aimovig include:1

  • Pain, redness, or swelling at the injection site
  • Constipation

These are not all the possible side effects of Aimovig. Talk to your doctor about what to expect when taking Aimovig. You also should call your doctor if you have any changes that concern you when taking Aimovig.

Other things to know

Before starting treatment with Aimovig, tell your doctor about all of your medical conditions.

There is not enough data to know if Aimovig is safe to take while pregnant or breastfeeding. Before starting treatment with Aimovig, tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. They can help you decide if Aimovig is right for you.1

Aimovig prefilled autoinjectors and prefilled syringes are not made with natural rubber latex.1

For more information, read the full prescribing information of Aimovig.

By providing your email address, you are agreeing to our privacy policy.